The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8480336 8644637 I 8480336-8 20120615 20120620 20120630 EXP AU-TEVA-344465ISR TEVA 48 YR F Y 20120630 CN AUSTRALIA

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8480336 1020135265 C MIRTAZAPINE 1
8480336 1020135264 C LEVOTHYROXINE SODIUM 1
8480336 1020135262 C CONDILOX 2
8480336 1020135261 PS COPAXONE 1 SUBCUTANEOUS 020622
8480336 1020135263 C DIGOXIN 1
8480336 1020135266 C VITAMIN D 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
8480336 1020135261 MULTIPLE SCLEROSIS

Outcome of event

Event ID OUTC COD
8480336 HO

Reactions reported

Event ID PT
8480336 ASTHMA
8480336 LOWER RESPIRATORY TRACT INFECTION
8480336 NASOPHARYNGITIS
8480336 DYSPNOEA

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
8480336 1020135261 20120612